News From The July Issue Of The Journal Chest
7/06/2011
COMBINATION ANTITHROMBOTIC THERAPY MAY INCREASE BLEEDING RISK A new study suggests that the use of combination antithrombotic therapy may increase the risk of clinically relevant bleeding in patients with atrial fibrillation (AF)...
A Decade Long Study Reveals Reduction In Lung Cancer Mortality With CT Scan Screening
7/05/2011
A new study, titled 'National Lung Screening Trial' (NLST), conducted by the American College of Radiology Imaging Network (ACRIN) and the National Cancer Institute's Lung Screening Study Group, has shown a twenty percent decline in mortality due to lung cancer among study participants who were screened with low-dose helical computed tomography (CT) compared to those screened with chest X-ray...
Takeda UK Launches New Presentation Of Leuprorelin Acetate - Prostap® DCS
7/05/2011
Takeda UK anounced today the launch of its leuprorelin acetate dual chamber pre-filled syringe, Prostap® DCS. The older version - Leuprorelin acetate (Prostap®) - used in the treatment for prostate cancer in men and endometriosis6,7 and uterine fibroids in women is expected to be replaced by an enhanced version - Prostap DCS® - by the end of October 2011...
Radiation Rates For Breast Cancer May Be Underestimated
7/05/2011
More breast cancer patients than previously believed may be receiving radiation treatments after breast-conserving surgery, a University of Michigan Comprehensive Cancer Center study shows...
Almirall, S.A. (ALM:MC) announces the launch, in Germany, of Sativex® for the treatment of spasticity in multiple sclerosis (MS) and the approval of Actikerall® for the treatment of hyperkeratotic actinic keratosis (grade I/II) in adult patients which will be launched on July 15th...
High epidermal growth factor receptor (EGFR) expression was a good predictor of which lung cancer patients would survive longer when cetuximab (Erbitux) was added to first-line chemotherapy, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC)...
Nearly 10 Percent Of Patients In Lung Cancer Mutation Consortium Display ALK Rearrangement
7/05/2011
ALK rearrangement has been found in 9.6% of lung cancer patients tested in the Lung Cancer Mutation Consortium, and MET amplification in another 4...
Genomic Stability In Lung Tumors Differs Between Smokers And Never-Smokers
7/05/2011
Lung adenocarcinomas in people who have never smoked show greater genome instability than those in smokers, supporting the theory that lung cancer in never smokers arises through different pathways, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC)...
Erlotinib For Lung Cancer Nearly Doubles Progression-Free Survival Vs. Chemotherapy
7/05/2011
In the first phase III study to include Western lung cancer patients, first-line treatment with erlotinib (Tarceva) nearly doubled progression-free survival compared with chemotherapy, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC)...
Utility Of CT Lung Cancer Screening Increased By Adjunctive Use Of 3-D Imaging System
7/05/2011
IASLC presentation addresses key issue from landmark NLST lung cancer study -- how to manage high rate of false positive results; lays out protocol for adjunctive use of noninvasive diagnostic test to clarify false positives from CT screening VisionGate, Inc...